A novel phenotype with features of basal cell nevus syndrome and basaloid follicular hamartoma syndrome

Journal of the American Academy of Dermatology

Volumn 65, Issue 1, 2011, Pages

  Waxweiler, Weston T ^a   Adigun, Chris G ^b   Groben, Pam ^b   Rubenstein, David S ^b,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; BASAL CELL NEVUS SYNDROME; BASALOID FOLLICULAR HAMARTOMA SYNDROME; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGENITAL TUMOR; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 79958849957     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.12.010     Document Type: Article

References (7)

1. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 1998;110:885-8. (Pubitemid 28237693)
2. Grachtchouk V, Grachtchouk M, Lowe L, Johnson T, Wei L, Wang A, et al. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J 2003;22:2741-51. (Pubitemid 36712370)
3. El-Darouti MA, Marzouk SA, Abdel-Halim MR, Zidan AZ, Fawzy MM. Basaloid follicular hamartoma. Int J Dermatol 2005;44:361-5. (Pubitemid 40691979)
4. Klein RD, Dykas DJ, Bale AE. Clinical testing for the nevoid basal cell carcinoma syndrome in a DNA diagnostic laboratory. Genet Med 2005;7:611-9. (Pubitemid 41753012)
5. Rayner CR, Towers JF, Wilson JS. What is Gorlin's syndrome? The diagnosis and management of the basal cell naevus syndrome, based on a study of thirty-seven patients. Br J Plast Surg 1977;30:62-7. (Pubitemid 8035588)
6. Jih DM, Shapiro M, James WD, Levin M, Gelfand J, Williams PT, et al. Familial basaloid follicular hamartoma: lesional characterization and review of the literature. Am J Dermatopathol 2003;25:130-7. (Pubitemid 36350458)
7. Sheng H, Goich S, Wang A, Grachtchouk M, Lowe L, Mo R, et al. Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res 2002;62:5308-16.